An Irish woman who headed Ireland’s medicine’s watchdog has been appointed to take over as Executive Director of the European ...

WHO celebrates FDA's nod to injectable lenacapavir for HIV prevention, promising easier adherence with biannual doses.

GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the prevention of HIV.

The US Food and Drug Administration (FDA) has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a ...

According to a new, comprehensive report from The Insight Partners, the pharmaceutical membrane filters market is growing ...

DEP, the most common plasticiser in softgels, is considered to have relatively low toxicity and is used in small amounts. The ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Key Takeaways in this ArticleThe global Artificial Intelligence in Genomics market is valued at USD 785.12 million in 2024 ...

The World Health Organization (WHO) welcomes the approval by the United States Food and Drug Administration (FDA) of ...